HCRT and Parkinson disease: Considering that the number of orexinergic neurons is decreased in patients with PD (108, 109) and that orexin administration partly ameliorates non-motor symptoms in a mouse model of PD (110), whether orexin receptor antagonists as hypnotics are advantageous for patients with PD needs to be carefully determined in future studies.